In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.


This content is past the free consultation date

It is only available to ACCA members, members with an all access option or Fellows of the ESC

It is only available to EACVI Members, members with an all access option or Fellows of the ESC

It is only available to EAPC Members, members with an all access option or Fellows of the ESC

It is only available to EAPCI Members, members with an all access option or Fellows of the ESC

It is only available to EHRA Members, members with an all access option or Fellows of the ESC

It is only available to HFA Members, members with an all access option or Fellows of the ESC

It is only available to ESC Pro members, members with an all access option or Fellows of the ESC

Get your access now Get your access now Get your access now Get your access now Get your access now Get your access now Get your access now
Association of key risk factors and their combinations on ischemic outcomes and bleeding in patients with invasively managed myocardial infarction in Sweden

Session The value of risk scores for assessment in acute coronary syndrome

Speaker Daniel Lindholm

Congress : ESC Congress

  • Topic : coronary artery disease, acute coronary syndromes, acute cardiac care
  • Sub-topic : Coronary Artery Disease - Epidemiology, Prognosis, Outcome
  • Session type : Advances in Science
  • FP Number : 1398

Authors : D Lindholm (Uppsala,SE), G Sarno (Uppsala,SE), D Erlinge (Lund,SE), B Svennblad (Uppsala,SE), P Hasvold (Södertälje,SE), M Janzon (Linköping,SE), T Jernberg (Stockholm,SE), S James (Uppsala,SE)

15 views

Authors:
D. Lindholm1 , G. Sarno1 , D. Erlinge2 , B. Svennblad1 , P. Hasvold3 , M. Janzon4 , T. Jernberg5 , S. James1 , 1Uppsala Clinical Research Center - Uppsala - Sweden , 2Lund University - Lund - Sweden , 3AstraZeneca NordicBaltic - Södertälje - Sweden , 4Linköping University - Linköping - Sweden , 5Karolinska Institute - Stockholm - Sweden ,

Citation:
European Heart Journal ( 2018 ) 39 ( Supplement ), 265

Background: In patients with myocardial infarction (MI), risk factors for bleeding and ischemic events tend to overlap, but the combined effects of these factors have scarcely been studied. We aimed to assess the combined impact of five established risk factors using nationwide registries.

Methods: Using SWEDEHEART and the National Patient Registry, patients hospitalized for MI and managed invasively in Sweden from 2006–2014 were included. The following five risk factors were considered for the primary ischemic outcome of cardiovascular death (CVD)/MI/stroke, and for the outcome major bleeding hospitalization: multivessel disease, diabetes mellitus, chronic kidney disease, prior MI, and age ≥65.

Results: During the study period, 100,879 patients had invasively managed MI, of whom 20,831 (20.6%) experienced CVD/MI/Stroke and 5,939 (5.9%) major bleeding, during a median follow-up of 3.6 years. The majority (53.5%) had two or more risk factors. With each added risk factor, there was a marked but gradual increase in incidence of the composite endpoint. This was also seen for bleeding, but to a lesser extent. Presence of all risk factors vs. only one was associated with a 5–9 times increased incidence of CVD/MI/Stroke, and a 2–4 times increased incidence of major bleeding (Figure).

Conclusions: The majority of patients with MI had two or more established risk factors. Increasing number of risk factors was associated with higher incidence of ischemic events, although this pattern was not as pronounced for major bleeding. The higher incidence of ischemic events in those with multiple risk factors highlights an unmet need for additional preventive measures.

Incidence (events per 100 person-years)

This content is available only to ACCA members, members with an all access option or Fellows of the ESC

This content is available only to EACVI Members, members with an all access option or Fellows of the ESC

This content is available only to EAPC Members, members with an all access option or Fellows of the ESC

This content is available only to EAPCI Members, members with an all access option or Fellows of the ESC

This content is available only to EHRA Members, members with an all access option or Fellows of the ESC

This content is available only to HFA Members, members with an all access option or Fellows of the ESC

This content is available only to ESC Pro members, members with an all access option or Fellows of the ESC



Based on your interests

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim, Bristol-Myers Squibb and Pfizer Alliance, and Novartis Pharma AG. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are